Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCGN-Oct-1 Citations (3)

Originally described in: Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.
Tanaka M, Herr W Cell. 1990 Feb 9;60(3):375-86.
PubMed Journal

Articles Citing pCGN-Oct-1

Articles
A novel mechanism for Ca(2+)/calmodulin-dependent protein kinase II targeting to L-type Ca(2+) channels that initiates long-range signaling to the nucleus. Wang X, Marks CR, Perfitt TL, Nakagawa T, Lee A, Jacobson DA, Colbran RJ. J Biol Chem. 2017 Oct 20;292(42):17324-17336. doi: 10.1074/jbc.M117.788331. Epub 2017 Sep 15. PubMed
Activated CaMKIIalpha Binds to the mGlu5 Metabotropic Glutamate Receptor and Modulates Calcium Mobilization. Marks CR, Shonesy BC, Wang X, Stephenson JR, Niswender CM, Colbran RJ. Mol Pharmacol. 2018 Dec;94(6):1352-1362. doi: 10.1124/mol.118.113142. Epub 2018 Oct 3. PubMed
MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels. Narva E, Taskinen ME, Lilla S, Isomursu A, Pietila M, Weltner J, Isola J, Sihto H, Joensuu H, Zanivan S, Norman J, Ivaska J. iScience. 2022 May 25;25(6):104459. doi: 10.1016/j.isci.2022.104459. eCollection 2022 Jun 17. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.